Moreover, previous studies have focused on the vanin-1/cysteamine arm of the pathway, which is thought to create a state of disease induction through participating in oxidative stress7, this perspective overlooked the vanin-1/ PA arm of the pathway which might hold promise in optimizing diabetes and its associated CVD management. The gene discussed is VNN1; the disease is diabetes mellitus.